节点文献
CTD合并肺动脉高压的临床研究
Clinical Study of CTD Combined With Pulmonary Hypertension
【摘要】 目的分析研究弥漫性结缔组织病合并肺动脉高,掌握疾病特性。方法筛选我院2016年5月至2017年5月收治的78例弥漫性结缔组织病(CTD)患者为研究对象,对所有患者的临床资料进行回顾性分析,对不同类型病发率、主要症状、自身抗体、实验室检验、治疗及预后等情况进行分析研究。结果混合性结缔组织病合并肺动脉高压的发生率最高,占比42.42%;关节炎、雷诺综合征是占比最高的临床表现。结论弥漫性结缔组织病(CTD)最为多见的并发症就是肺动脉高压,其中混合性结缔组织病、系统性硬化症病发率最高,主要呈现关节炎、雷诺征,患者要做好疾病监测,发现患病及时治疗,若发展到重度即使治疗也会有着较高的死亡率。
【Abstract】 Objective To study the characteristics of diffuse connective tissue disease combined with pulmonary artery height. Methods 78 cases of diffuse connective tissue disease(CTD) admitted by our hospital from May 2016 to May 2017 were screened as subjects. The clinical data of all patients were retrospectively analyzed, and different types of disease rates, main symptoms, autoantibodies, laboratory tests, treatment and prognosis were analyzed. Results The incidence of mixed connective tissue disease complicated with pulmonary hypertension was the highest, accounting for 42.42%. Arthritis and Raynaud’s syndrome were the highest clinical manifestations. Conclusion The most common complication of diffuse connective tissue disease(CTD) is pulmonary hypertension. The incidence of mixed connective tissue disease and systemic sclerosis is the highest. The main symptoms are arthritis and Renault. Patients should be monitored for disease. It is found that the disease is treated promptly, and if it progresses to severe, even if it is treated, it will have a higher mortality rate.
【Key words】 Diffuse connective tissue disease; Pulmonary hypertension; Clinical study;
- 【文献出处】 世界最新医学信息文摘 ,World Latest Medicine Information , 编辑部邮箱 ,2018年97期
- 【分类号】R544.1;R593.2
- 【被引频次】1
- 【下载频次】75